Navigation Links
Northstar announces that its much-anticipated pet healthcare product will go on sale April 17th
Date:4/11/2013

HOLBROOK, N.Y., April 11, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc., Symbol (OTCPink: MDIN), today announced that on April 17th, it will begin to sell HealthEnrich For Pets, a pet healthcare product that is aimed at reversing the aging process and debilitating symptoms of old age in pets utilizing the anti-oxidant, anti-inflammatory, and stem cell replacement properties of the company's proprietary blend of aquatic algae extracts. Currently in talks with at least two major players in the pet industry about distribution and possible licensing, Northstar will begin selling HealthEnrich for Pets on its own website at www.medgeninc.com, and through Amazon.com, but the company expects shipping for nationwide retail distribution to begin shortly thereafter.

The unique properties of the extracts target the painful joints, poor eyesight, low energy, and muscle degeneration that plagues aging dogs and cats, especially pure breeds. "Not only does this product reduce the swelling in joints, and make the animal feel younger and full of energy because of its very potent anti-oxidant and anti-inflammatory properties, but because the active ingredients have the very rare effect of flooding the body with adult stem cells, it allows the pet to heal and re-generate muscle at an astonishing rate," said the company CEO, Nick Chieco . "And I have seen it first hand. My good friend's aging pure breed Pug was practically blind and lame when he started mixing just a few milligrams of the product into the dog's food. Thirty days later I could not recognize the dog, which was running around in circles and chasing squirrels like a puppy. After seeing it with my own eyes, I knew this had to be our next product release."

The company has retooled the product since first announcing its creation. Originally designed to be a daily dog treat, the product is now a liquid that can be easily added to the animal's drinking water. A few drops per day and a generous dose of the all-natural blue-green algae extracts will begin shaving years off of your dog or cat's age. Why a liquid? The company maintains that because the packaging is less expensive, it takes up less room and there is no baking or drying process, the overhead was cut tremendously allowing for a lower retail price and a higher profit margin. The product will retail for $19.99 for a one-month supply and costs the company just under $2.00 per bottle to make. High margins and rapidly increasing revenue are nothing new to Northstar, as you can tell from the company's second quarter disclosure for 2013. The company surprised the world as they showed more than five million dollars in revenue, and is operating in the black, after just three months of sales. The company feels that this product, because of its multi-billion dollar market will put Northstar on the map, and could one day make the company a household name. Until then the company prepares for what it thinks will be overwhelming orders come April 17th. Anyone interested in Northstar or its products can visit www.medgeninc.com, or call Jennifer at 877-571-4387 or email investors@northstarbb.com

About Northstar
Northstar Global Business Services is dedicated to producing the best alternative healthcare products. The most popular products in Northstar's arsenal are Snorenz©, a patented spray for snoring relief and Stem-Intense, a unique stem cell replacement therapy supplement. Most of the company's products use a unique spray delivery system, and have received very positive consumer reviews all over the world, selling millions upon millions of units from 1996 to the present.

DISCLAIMER
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.


'/>"/>
SOURCE Northstar Global Business Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):